Skip to content

Clinical trials

Mental Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: Germany Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20082
20102
20116
20126
20133
20144
20153
20163
20174
20185
20194
202015
20215
20224
20232
20243
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Unknown status12
Terminated7
Not yet recruiting5
Enrolling by invitation2
Suspended2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany18
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Universitätsklinikum Hamburg-Eppendorf4
AstraZeneca3
University Hospital Tuebingen3
Goethe University2
Jacobs University Bremen gGmbH2
Max-Planck-Institute of Psychiatry2
Medizinische Hochschule Brandenburg Theodor Fontane2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders81
Dementia13
Nervous System Diseases12
Brain Diseases11
Alzheimer Disease10
Central Nervous System Diseases10
Major Depressive Disorder9
Anxiety Disorders8
Depressive Disorder8
Mood Disorders8

Trials

Showing 26 to 50 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.